Literature DB >> 34872062

Screening for Chronic Infectious Diseases by Serology in Those Presenting with Malaria in London, United Kingdom.

Alison Gowland1, Emma McGuire1, Anna L Goodman1.   

Abstract

The United Kingdom's cases of malaria infection are primarily acquired in sub-Saharan Africa, with the majority of infections presenting in London.1 When patients go to a hospital with malaria, there is a screening opportunity for other geographically associated chronic infections. We identified patients who were diagnosed with malaria after presenting to our emergency department in London over a 2-year period, to assess whether there may be clinical benefit in screening for chronic viral (hepatitis B, hepatitis C, HIV) or parasitic (schistosomiasis, strongyloidiasis) infection in this cohort. Over this period, 131 patients were diagnosed with malaria. Crude seropositivity rates for HIV, hepatitis B, and strongyloidiasis were higher than expected compared with local population estimates, 7 and 28 times higher for HIV and hepatitis B, respectively. Those patients with previously unidentified cases were offered appropriate treatment. These findings support the potential clinical and public health benefits of screening for other infectious diseases in the context of a malaria diagnosis.

Entities:  

Mesh:

Year:  2021        PMID: 34872062      PMCID: PMC8832911          DOI: 10.4269/ajtmh.20-1217

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  8 in total

1.  Incidence rate and risk factors for giardiasis and strongyloidiasis in returning UK travellers.

Authors:  Kensuke Takaoka; Yannis Gourtsoyannis; John D Hart; Margaret Armstrong; Amanda Daniel; Emma Mewse; Diana Phillips; Robin L Bailey
Journal:  J Travel Med       Date:  2016-07-18       Impact factor: 8.490

2.  Schistosomiasis presenting in travellers: a 15 year observational study at the Hospital for Tropical Diseases, London.

Authors:  Cordelia E M Coltart; Anastasia Chew; Neill Storrar; Margaret Armstrong; Natalie Suff; Leila Morris; Peter L Chiodini; Christopher J M Whitty
Journal:  Trans R Soc Trop Med Hyg       Date:  2015-01-08       Impact factor: 2.184

3.  False-positive serological tests in acute malaria.

Authors:  K Ghosh; K N Javeri; D Mohanty; B D Parmar; R R Surati; S H Joshi
Journal:  Br J Biomed Sci       Date:  2001       Impact factor: 3.829

4.  How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review.

Authors:  Farah Seedat; Sally Hargreaves; Laura B Nellums; Jing Ouyang; Michael Brown; Jon S Friedland
Journal:  Lancet Infect Dis       Date:  2018-05-16       Impact factor: 25.071

5.  Effectiveness of Screening and Treatment Approaches for Schistosomiasis and Strongyloidiasis in Newly-Arrived Migrants from Endemic Countries in the EU/EEA: A Systematic Review.

Authors:  Eric N Agbata; Rachael L Morton; Zeno Bisoffi; Emmanuel Bottieau; Christina Greenaway; Beverley-A Biggs; Nadia Montero; Anh Tran; Nick Rowbotham; Ingrid Arevalo-Rodriguez; Daniel T Myran; Teymur Noori; Pablo Alonso-Coello; Kevin Pottie; Ana Requena-Méndez
Journal:  Int J Environ Res Public Health       Date:  2018-12-20       Impact factor: 3.390

6.  Community-based testing of migrants for infectious diseases (COMBAT-ID): impact, acceptability and cost-effectiveness of identifying infectious diseases among migrants in primary care: protocol for an interrupted time-series, qualitative and health economic analysis.

Authors:  Manish Pareek; Helen C Eborall; Fatimah Wobi; Kate S Ellis; Evangelos Kontopantelis; Fang Zhang; Rebecca Baggaley; T Deirdre Hollingsworth; Darrin Baines; Hemu Patel; Pranabashis Haldar; Mayur Patel; Iain Stephenson; Ivan Browne; Paramjit Gill; Rajesh Kapur; Azhar Farooqi; Ibrahim Abubakar; Chris Griffiths
Journal:  BMJ Open       Date:  2019-03-07       Impact factor: 2.692

7.  UK malaria treatment guidelines 2016.

Authors:  David G Lalloo; Delane Shingadia; David J Bell; Nicholas J Beeching; Christopher J M Whitty; Peter L Chiodini
Journal:  J Infect       Date:  2016-02-12       Impact factor: 6.072

8.  An innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a London Emergency Department.

Authors:  Hannah Evans; Sooria Balasegaram; Sam Douthwaite; Laura Hunter; Ranjababu Kulasegaram; Terry Wong; Antonio Querol-Rubiera; Gaia Nebbia
Journal:  PLoS One       Date:  2018-07-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.